COMMENT The FDA is often criticized because it is viewed as creating biological and drug product shortages when it issues a FDA 483, Warning Letter, Consent Decree or executes a seizure.  This Alert published by the FDA demonstrates several of the actions that the FDA may initiate to minimize these shortages.  In addition, the FDA now typically adds a "boilerplate" paragraph … [Read more...]